they were desperately looking for a way to reverse out of their murderous Blood policy.
Actually, their 'murderous blood policy' was a benefit in this situation. It is that policy that makes for the control group and also creates a 'compassionate' group that speeds the process of approval up. Compassionate use serves a distinct purpose for the pharma companies, in addition to being used for 'patients who are going to die anyways'. If the blood ban was given up, there would no longer be a pressing 'need' to get some products on the market. Compassionate use is often the toehold that is needed by some companies.
I had said earlier that the WTS approved Hemopure in 2000 but there is evidence in the literature that JWs were being given Hemopure before the 'official approval'. The medical literature, at least those studies and trials which have made it to publication, has examples of procedures being done on JW patients long before the Society gave approval on the procedures.
"Volume expanders had been developed back in the 60s by using JW subjects in research facillitated by the Army. (yes...I can back that up...I have the study that shows that...)"
I wouldn't mind seeing that.
The study can be found in this book here:

The book was published by the Watchtower Society and placed with medical professionals across Canada. I don't know if it was used in any other country.
I don't know if you can access this study digitally, but a hard copy would certainly be found in the Society's library.
Electrolyte Solution in Surgical Patients Refusing Transfusion
Seymour Gollub, PhD, MD; Robert Svigals, MD; Charles P. Bailey, MD; Teruo Hirose, MD; and Clara Schaefer
(from St. Barnabas Hospital, Bronx, NY)
Originally published in The Journal of American Medical Association, March 29, 1971, Vol. 215, no. 13
Abstract:
Major blood loss in 13 surgical patients was treated by infusion of crystalloid solution alone, supplemented by colloid plasma expander when necessary. Neither whole blood nor any of its components or fractions was employed at any time. For losses of 21% to 66% of blood volume, Ringer’s solution administered in three to five times the volume of blood loss, produced significant intravascular fluid increments equaling one fifth to three fifths of the shed blood. Colloid solutions were required to sustain blood volumes or blood pressure for patients with blood losses in excess of 1,200 ml, otherwise clinically significant edema was manifested. One week after surgery, blood volumes averaged 90% of original values. The death rate was three thirteenths. The average hospital stay was prolonged 3.4 days.
And this small note just prior to the reference list at the end of the article:
This investigation was supported by the John A. Hartford Foundation and aided by the US Army Surgical Research and Development Command.
about the study:
This communication presents a body of clinical experience with exclusive use of crystalloid solution as alternate therapy to blood transfusion in cases of high-trauma surgery with major blood loss. Though it describes, in many ways, extremes of clinical practice, it may contribute to a clearer understanding of results of nonhemic fluid resuscitation, and help to define safe limits of its employment.
The subjects:
Thirteen consecutively studied cases of a group of surgical patients subjected to a wide range of traumatice procedures are presented. All sustained major blood loss. None received blood or any blood fraction at any time. All were members of the Jehovah’s Witness faith.
I have the entire study scanned, if you are interested. But the quality isn't great.